Search

Search Constraints

You searched for: Author/Creator Puig, Noemí

Search Results

1. 6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival. (11th August 2020)

2. Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder. Issue 1 (2nd January 2020)

3. Identification of relapse‐associated gene mutations by next‐generation sequencing in low‐risk acute myeloid leukaemia patients. (2nd March 2020)

4. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma. Issue 1 (31st July 2015)

5. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma. Issue 1 (31st July 2015)

6. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry. Issue 1 (December 2016)

7. Origin of Waldenstrom's macroglobulinaemia. Issue 2 (June 2016)

8. Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem‐cell transplantation is a prognostic marker of longer progression‐free survival and overall survival. (5th April 2022)

9. Reply to Brown et al: 'Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis'. Issue 1 (2nd January 2020)

10. Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM). Issue 14 (6th December 2022)